Axcella Health Statistics Share Statistics Axcella Health has 2.73M
shares outstanding. The number of shares has increased by -94.39%
in one year.
Shares Outstanding 2.73M Shares Change (YoY) -94.39% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 1.07M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 5.56K, so 0% of the outstanding
shares have been sold short.
Short Interest 5.56K Short % of Shares Out n/a Short % of Float 0.02% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -6.46 and the forward
PE ratio is null.
Axcella Health's PEG ratio is
0.23.
PE Ratio -6.46 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 125.9 P/FCF Ratio -7.49 PEG Ratio 0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Axcella Health.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.21,
with a Debt / Equity ratio of 0.52.
Current Ratio 1.21 Quick Ratio 1.21 Debt / Equity 0.52 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage -24.1
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-7.38M Employee Count 11 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 0.57, so Axcella Health's
price volatility has been higher than the market average.
Beta 0.57 52-Week Price Change n/a 50-Day Moving Average 3.09 200-Day Moving Average 7.38 Relative Strength Index (RSI) 73.86 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -72.8M Net Income -81.19M EBITDA -67.01M EBIT -78.17M Earnings Per Share (EPS) -1.27
Full Income Statement Balance Sheet The company has 17.15M in cash and 2.16M in
debt, giving a net cash position of 14.99M.
Cash & Cash Equivalents 17.15M Total Debt 2.16M Net Cash 14.99M Retained Earnings -418.43M Total Assets 9.28M Working Capital -2.27M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -69.59M
and capital expenditures -426K, giving a free cash flow of -70.01M.
Operating Cash Flow -69.59M Capital Expenditures -426K Free Cash Flow -70.01M FCF Per Share -1.09
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields AXLA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for AXLA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 19, 2023. It was a
backward
split with a ratio of 1:25.
Last Split Date Sep 19, 2023 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -80.1 Piotroski F-Score 3
